Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Bone grafting material, dental, with biologic component

Número de PMA: P040013 · 2026-08-03

SolicitanteLynch Biologics, LLC
Fecha de decisión2026-08-03
Número PMAP040013
Código de productoNPZ
Clase del dispositivoClase 3
Especialidad médicaD
Número de regulación21 CFR 8
Comité asesorDE

Resumen del dispositivo

Bone grafting material, dental, with biologic component is the device name listed in this FDA 510(k) record. The listed applicant is Lynch Biologics, LLC. It received FDA 510(k) clearance on 2026-08-03. The device is classified under product code NPZ. It was reviewed by the DE advisory panel.

Preguntas frecuentes

What is the Bone grafting material, dental, with biologic component?

Bone grafting material, dental, with biologic component is a medical device that received FDA 510(k) clearance on 2026-08-03. The listed applicant is Lynch Biologics, LLC.

When did Bone grafting material, dental, with biologic component receive FDA 510(k) clearance?

The clearance date for Bone grafting material, dental, with biologic component can be found in the official FDA records.

Who is the listed applicant for Bone grafting material, dental, with biologic component?

The FDA 510(k) record lists Lynch Biologics, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Bone grafting material, dental, with biologic component?

The FDA product code for Bone grafting material, dental, with biologic component is NPZ.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑